Embassy Suites Atlanta – at Centennial Olympic Park · Atlanta, Georgia, USA · November 4-5, 2010
Chairs: John Loughlin, PhD, Ingrid Meulenbelt, PhD, Virginia Byers Kraus, MD, PhD, Linda Sandell, PhD
Session 1
Biochemical Biomarkers – Progress Since the First Workshop
Linda Sandell, PhD / Virginia Byers Kraus, MD, PhD
OA Phenotypes – Gathering Clinical Clues to Help Resolve Genetic Heterogeneity
George Moxley, MD
Virginia Commonwealth University
Session 2
OA Genome-wide Association Scans from Across the Globe
Ele Zeggini, PhD
Wellcome Trust Sanger Institute, UK
The OAI GWAS
Rebecca Jackon, MD
Ohio State University
Session 3
Meta-analyses and Replicated Loci
Kay Chapman, PhD
University of Oxford, UK
Session 4
Deep Sequencing, Rare Variant Analysis & Other Strategies for Mapping OA Loci
Steffan Daniel Bos, PhD
LUMC, The Netherlands
Functional Studies: Pathways and Biomarkers
Ingrid Meulenbelt, PhD
LUMC, The Netherlands
Session 5
Cartilage Transcriptomics and Epigenetics – Insights into OA
David Young, PhD
Newcastle University, UK
Osteoarthritis Candidate Genes Identified by Genome-Wide Expression Profiling of Cartilage and their Relevance for OA Joint Repair Tissue Engineering Applications
Jochen Ringe
Charité University Medicine, Germany
Session 6
The Additive Prediction of OA Risk Alleles Using the Rotterdam Study
Joyce van Meurs, PhD
Erasmus Medical Centre, Rotterdam, The Netherlands
Chondrocyte Genomics – Implications for Disease Modification in OA
K. Wayne Marshall, MD, PhD
GeneNews, Canada
Session 7
Genomic Diagnostics – Lessons from Allomap
Robert Woodward, PhD
XDx, Inc.
Future Clinical Exploitation of OA Genetics and Genomics
Ken Kornman, DDS, PhD
Interleukin Genetics
Panel Discussion
Steven Abramson, MD (USA), David Hunter, MD, PhD (Australia), Joanne Jordan, MD, MPH (USA), Nancy Lane, MD (USA), Anthony Robin Poole, PhD, DSc (Canada)